Clinical Trials Directory

Trials / Completed

CompletedNCT02186808

T-116_Procera-Bridge Zirconia - A Clinical Study

Procera-Bridge Zirconia - A Clinical Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Nobel Biocare · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The objective of the study is to evaluate the clinical performance of Procera® Bridge Zirconia veneered with NobelRondo Zirconia.

Detailed description

The study was designed to be an open, 5-year, prospective, multi-center clinical post-market study. The objectives of this clinical study were that industrial centrally produced 3- or 4-unit bridges of yttrium-oxide partially-stabilized (Y-TZP) zirconia (Procera Zirconia) in combination with the veneering ceramic material NobelRondo will show sufficient CDA ratings (90% R+S) and a sufficient survival rate after 1 and 5 years.

Conditions

Interventions

TypeNameDescription
DEVICEProcera® Bridge ZirconiaPatients planned for treatment with a tooth-supported 3 to 4-unit bridge in any position of the maxilla or the mandible.

Timeline

Start date
2005-05-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2014-07-10
Last updated
2016-10-27
Results posted
2016-04-25

Source: ClinicalTrials.gov record NCT02186808. Inclusion in this directory is not an endorsement.